Kura Oncology Funding & Investors
Kura Oncology, Inc. operates as a clinical stage biopharmaceutical company. The Company focuses on discovery and development of personalized therapeutics for the treatment of tumors and blood cancers. Kura Oncology offers development programs for cancers with high unmet need, including lung, colorectal, thyroid, blood, and pancreatic cancers.
kuraoncology.comTotal Amount Raised: $360,000,000
Kura Oncology Funding Rounds
Post Ipo Equity
$150,000,000
Post Ipo Equity Investors
Suvretta Capital ManagementEcoR1 CapitalDeerfield ManagementPost Ipo Debt
$125,000,000
Post Ipo Debt Investors
Hercules CapitalPrivate Equity
$60,000,000
Private Equity Investors
EcoR1 CapitalArch Venture PartnersNextech InvestOUP (Osage University Partners)Fidelity InvestmentsTavistock GroupPartner Fund ManagementPost Ipo Equity
$25,000,000
Post Ipo Equity Investors
Bristol-Myers Squibb
Funding info provided by Diffbot.